U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF
THE SECURITIES EXCHANGE ACT OF 1934
Abacus Life, Inc.
(Exact Name of Registrant as Specified in Its Charter)
Delaware | 85-1210472 | |
(State of Incorporation or Organization) | (I.R.S. Employer Identification No.) | |
2101 Park Center Drive, Suite 170 Orlando, Florida |
32835 | |
(Address of Principal Executive Offices) | (Zip Code) |
Securities to be registered pursuant to Section 12(b) of the Act:
Title of Each Class to be Registered |
Name of Each Exchange on Which Each Class is to be Registered | |
9.875% Notes due 2028 | The Nasdaq Stock Market LLC |
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), please check the following box. ☒
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), please check the following box. ☐
If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. ☐
Securities Act registration statement file number to which this form relates:
333-274553
(If applicable)
Securities to be registered pursuant to Section 12(g) of the Act:
N/A
(Title of Class)
INFORMATION REQUIRED IN REGISTRATION STATEMENT
Item 1. | Description of Registrants Securities to be Registered. |
This Form 8-A is being filed in connection with the offering of 9.875% Fixed Rate Senior Notes due 2028 (the Notes) of Abacus Life, Inc., a Delaware corporation (the Registrant). The Notes are expected to be listed on the Nasdaq Global Market and to trade thereon within 30 days of the original issue date under the trading symbol ABLLL. As of November 10, 2023, the Registrant had sold and issued $35,650,000 in aggregate principal amount of the Notes, which includes $4,650,000 in aggregate principal amount sold pursuant to a fully-exercised underwriter overallotment option.
A description of the Notes is incorporated herein by reference to the Description of the Notes in the Registrants final prospectus, as filed with the Securities and Exchange Commission (the SEC) on November 6, 2023 under Rule 424(b)(3) under the Securities Act of 1933, as amended, relating to the Registrants Registration Statement on Form S-1 (Registration No. 333-274553), as amended.
Item 2. | Exhibits. |
The following exhibits have been filed as exhibits to this registration statement on Form 8-A and are incorporated herein by reference:
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereto duly authorized.
ABACUS LIFE, INC. | ||
By: | /s/ Jay J. Jackson | |
Jay J. Jackson | ||
Chairman of the Board, President and Chief Executive Officer |
Date: November 20, 2023